Wyniki wyszukiwania:

Generic drugs are now familiar objects in clinics, drugstores, and households around the world. We like to think of these tablets, capsules, patches, and ointments as interchangeable with their brand-name counterparts: why pay more for the same? And yet they are not quite the same. They differ in price, in place of origin, in color, shape, and size, in the dyes, binders, fillers, and coatings used, and in a host of other ways. Claims of generic equivalence, as physician-historian Jeremy Greene reveals in this gripping narrative, are never based on being identical to the original drug in...

The second half of the twentieth century witnessed the emergence of a new model of chronic disease--diagnosed on the basis of numerical deviations rather than symptoms and treated on a preventive basis before any overt signs of illness develop--that arose in concert with a set of safe, effective, and highly marketable prescription drugs. In Prescribing by Numbers, physician-historian Jeremy A. Greene examines the mechanisms by which drugs and chronic disease categories define one another within medical research, clinical practice, and pharmaceutical marketing, and he explores how...

Generic drugs are now familiar objects in clinics, drugstores, and households around the world. We like to think of these tablets, capsules, patches, and ointments as interchangeable with their brand-name counterparts: why pay more for the same? And yet they are not quite the same. They differ in price, in place of origin, in color, shape, and size, in the dyes, binders, fillers, and coatings used, and in a host of other ways. Claims of generic equivalence, as physician-historian Jeremy Greene reveals in this gripping narrative, are never based on being identical to the original drug in...

America has had a long love affair with the prescription. It is much more than the written -script- or a manufactured medicine, professionally dispensed and taken, and worth hundreds of millions of dollars a year. As an object, it is uniquely illustrative of the complex relations among the producers, providers, and consumers of medicine in modern America.

The tale of the prescription is one of constant struggles over and changes in medical and therapeutic authority. Stakeholders across the biomedical enterprise have alternately upheld and resisted, supported and critiqued, and...

This collection challenges the historical accuracy of this revolutionary narrative and offers instead a more nuanced account of the process of therapeutic innovation and the relationships between the development of medicines and social change. These assembled histories...

This collection challenges the historical accuracy of this revolutionary narrative and offers instead a more nuanced account of the process of therapeutic innovation and the relationships between the development of medicines and social change. These assembled histories...